1996
DOI: 10.1074/jbc.271.27.16253
|View full text |Cite
|
Sign up to set email alerts
|

Adenovirus-mediated Transfer of a Truncated Transforming Growth Factor-β (TGF-β) Type II Receptor Completely and Specifically Abolishes Diverse Signaling by TGF-β in Vascular Wall Cells in Primary Culture

Abstract: We constructed an adenoviral vector expressing a mutated human type II transforming growth factor-␤ (TGF-␤) receptor that was truncated of its kinase domain (AdexCAT␤TR) and examined whether this truncated receptor could abolish signaling by TGF-␤ using

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
71
0
1

Year Published

1998
1998
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 84 publications
(76 citation statements)
references
References 46 publications
4
71
0
1
Order By: Relevance
“…However, our ®ndings are in agreement with several previous reports. In Mv1Lu cells expression of a truncated TbRII or a mutant TbRI that lacks the juxtamembrane region preceding the GS domain does not attenuate TGF-b1 mediated induction of PAI-I (Yamamoto et al, 1996;Saitoh et al, 1996). None- Figure 6 E ects of Smad7 on PAI-I induction and 3TP-luciferase activity.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, our ®ndings are in agreement with several previous reports. In Mv1Lu cells expression of a truncated TbRII or a mutant TbRI that lacks the juxtamembrane region preceding the GS domain does not attenuate TGF-b1 mediated induction of PAI-I (Yamamoto et al, 1996;Saitoh et al, 1996). None- Figure 6 E ects of Smad7 on PAI-I induction and 3TP-luciferase activity.…”
Section: Discussionmentioning
confidence: 99%
“…Data are expressed as mean+s.e.mean of three independent experiments. *P50.05 theless, these cells are resistant to the antiproliferative e ects of TGF-b1 (Yamamoto et al, 1996;Saitoh et al, 1996). Furthermore, transient overexpression of a Smad3 protein in which the three C-terminal serines have been replaced by aspartic acid blocks the antiproliferative e ects of TGF-b1 in Mv1Lu cells, while still allowing for activation of PAI-I transcription (Liu et al, 1997).…”
Section: Discussionmentioning
confidence: 99%
“…[21][22][23][24][25] Briefly, a cDNA coding for human wild-type p53 (kindly provided by Dr Vogelstein, Johns Hopkins Oncology Center, Program in Human Genetics, Baltimore, MD, USA) was placed into a cassette cosmid vector, pAdexCA1w (provided by Dr Saito, University of Tokyo), under a CA promoter comprising a cytomegalovirus enhancer and chicken ␤-actin promoter (pAdex1w/p53). A recombinant adenovirus was constructed by in vitro homologous recombination in 293 cells using pAdex1w/p53 and the adenovirus DNA-terminal protein complex.…”
Section: Preparation Of Adenoviral Vectorsmentioning
confidence: 99%
“…16,17,26,27 AdCALacZ was purified by ultracentrifugation through a CsCl 2 gradient followed by extensive dialysis. The titer of the virus stock was assessed by a plaque formation assay using 293 cells and expressed as plaque formation units (p.f.u.).…”
Section: Adenoviral Vectormentioning
confidence: 99%
“…The electroretinographical evaluations were performed as previously described. 17,26 The rats were anesthetized with an intraperitoneal injection of 15 ml/g body weight of saline solution containing katamine (1 mg/ml), myoblock (0.4 mg/ml), and urethane (40 mg/ml). Both pupils were dilated with mydrin (2.5% phenylephrine HCl and 0.5% tropicamide content; Santen, Osaka, Japan), and the animals were placed on a heating pad.…”
Section: Electroretinograms (Ergs)mentioning
confidence: 99%